Minnesota Court Lets Computer Duster Inhalation Lawsuit Proceed Against Makers and Retailers

A computer duster inhalation lawsuit will go forward in Minnesota federal court after Judge Katherine M. Menendez declined on 18 September 2026 to dismiss a putative class action brought over the death of a man who intentionally inhaled the contents of an aerosol duster can. The court held that it cannot yet be determined whether the manufacturer defendants adequately warned that misusing their products could kill, and separately held that Minnesota's statutory protection for non-manufacturing sellers does not defeat the claims against the retailer defendants, because those retailers are alleged to have participated in the products' design, manufacturing and distribution.

Two rulings in one order, and the second is the one that will be read hardest. A failure to warn claim surviving a motion to dismiss is unremarkable; warning adequacy is ordinarily a fact question. Holding that a retailer has pleaded its way out of Minn. Stat. § 544.41 is not unremarkable at all, because that statute is the mechanism by which retail defendants normally leave duster cases early, and leaving early is how they have avoided the discovery that makes these cases expensive.

What did the Minnesota federal court decide in the computer duster inhalation case?

The court decided two things and deferred everything else. First, on the manufacturers: the question whether the warnings on the cans adequately conveyed that misuse could cause death is not resolvable on the pleadings, so the failure to warn claims proceed to a factual record. Second, on the retailers: the "sellers exception" in Minn. Stat. § 544.41 does not knock them out, because the complaint alleges they participated in the design, manufacture and distribution of the products rather than merely stocking somebody else's can.

Several things a practitioner would normally want are not in the available reporting, and it is worth naming them rather than guessing:

• the case caption, the docket number, and the identity of the decedent;
• which manufacturers and which retailers are named, and whether any private-label arrangement is pleaded;
• the class definition, and whether the class claims are consumer protection claims running alongside individual wrongful death and survival claims;
• whether design defect claims were also pleaded, and if so how they fared;
• whether punitive damages remain in the case.

Those gaps matter to how far the ruling travels. An order resting on detailed allegations of a private-label relationship — a retailer specifying the formulation, the can, the label — is a narrow ruling about pleading. An order resting on generic allegations of "participation" would be a much wider one. Until the opinion is on a public docket, the safe reading is the narrow one.

The product, the gas and the way people die from it

Aerosol computer dusters are sold as compressed-air cleaners for keyboards and electronics. Most contain little or no air. The propellant in the widely litigated brands is 1,1-difluoroethane, or DFE, an odourless fluorinated hydrocarbon that produces intense and near-instant intoxication when inhaled directly from the can. The practice is called huffing or dusting, and the cans are cheap, legal for anyone to buy in most states, and sold in the same aisle as printer paper.

The pharmacology is what makes these cases different from ordinary misuse cases. DFE displaces oxygen and sensitises the myocardium to catecholamines, which is the mechanism behind what clinicians call sudden sniffing death syndrome: a first-time or hundredth-time user goes into cardiac arrest, sometimes within seconds, sometimes while startled mid-inhalation. Chronic use produces a separate injury profile, including vitamin B12 depletion and subacute combined degeneration of the spinal cord. A death can therefore be acute and unforeseeable to the user, or the endpoint of a documented addiction. Both fact patterns are in the pleadings across the country.

The scale is not trivial. The Consumer Product Safety Commission's injury clearinghouse recorded 1,115 deaths and approximately 28,800 emergency room visits involving DFE inhalation between 2006 and 2022. The products named in the class complaints filed to date include AW's Ultra Duster, Falcon Safety Products' Dust-Off and Norazza's Endust, with Walmart named in at least one complaint as a private-label retail partner.

Several manufacturers add denatonium benzoate, an intensely bitter compound, as a huffing deterrent. Plaintiffs have made that additive an affirmative part of their case rather than a defence to it, alleging both that the bitterant is not present in the gas phase in usable quantities and that denatonium is a bronchodilator, so that adding it may widen the airway and increase the dose of DFE actually absorbed. That is an unusual allegation: it converts a safety feature into evidence of a design defect and, more importantly for the Minnesota ruling, into evidence of what the defendants knew about the misuse they were designing around.

Can you sue a computer duster manufacturer if someone intentionally inhaled the product?

Sometimes, and where you file determines the answer more than what happened does. The intentional character of the misuse is not automatically fatal to a claim, because American product liability law has long held manufacturers to account for reasonably foreseeable misuse, and a manufacturer that adds a deterrent to a product has some difficulty arguing that the misuse it deterred was unforeseeable. But three separate doctrines stand in the way, and each has carried the day somewhere in the last eighteen months.

The first is the illegality defence: several states bar recovery for injuries sustained in the course of the plaintiff's own unlawful act. The second is the design defect standard: proving a product is defective is not enough, since most jurisdictions also require proof that it was unreasonably dangerous, and a can of solvent that performs exactly as designed when used as directed is a hard fit. The third is the non-manufacturer seller statute, which removes retailers and distributors from strict liability claims unless a statutory exception applies. The September order engages the third and the warnings branch of the first; the Eighth Circuit disposed of the second in February.

What is Minnesota's seller exception statute and when does it stop protecting a retailer?

Minn. Stat. § 544.41 is a failure to warn defendant's favourite provision and the reason retailer participation was the contested issue. In any product liability action resting in whole or in part on strict liability in tort brought against a defendant other than the manufacturer, the statute requires that defendant, on answering or otherwise pleading, to file an affidavit certifying the correct identity of the manufacturer. Once the manufacturer has been identified and is subject to the court's jurisdiction, the non-manufacturing seller is ordinarily dismissed from the strict liability claims.

The protection is not unconditional. A seller stays in the case if any of three things is alleged and proved:

1. the defendant exercised some significant control over the design or manufacture of the product, or gave the manufacturer instructions or warnings relating to the alleged defect;
2. the defendant had actual knowledge of the defect that caused the injury or death; or
3. the defendant created the defect.

The 18 September order turns on the first exception. Allegations that the retailer defendants participated in design, manufacture and distribution take them outside the ordinary operation of the statute at the pleading stage, which means they stay for discovery — and discovery is where retailer-side documents about placement, pricing, age-verification practice, loss-prevention data on theft of duster cans, and internal correspondence about inhalant abuse would be produced. That is the practical significance of the holding. It is not a liability finding. It is an exposure to document production that retailers in these cases have previously escaped.

Minnesota already regulates this product at retail: Minn. Stat. § 325F.078 governs the sale of aerosol dusters containing DFE. A statute directed at the retail channel is not itself proof of a duty, but it is not nothing when a plaintiff argues that a retailer knew precisely why its inventory moved.

Why the Eighth Circuit's McDougall reversal makes this ruling more important, not less

Seven months before the September order, the Eighth Circuit handed the duster industry its most significant win. In McDougall v. CRC Industries, Inc., No. 24-3614, decided 25 February 2026, Judge Jonathan A. Kobes, joined by Judges James B. Loken and Lavenski R. Smith, reversed a Minnesota jury verdict and remanded for entry of judgment as a matter of law for the manufacturer.

The underlying facts were about as sympathetic as a plaintiff could assemble. Cynthia McDougall, 42, was killed in a head-on collision near Baudette, Minnesota in July 2019 by a driver who had been huffing CRC's duster. Her husband sued in the District of Minnesota, No. 0:20-cv-01499, on failure to warn and design defect theories. In April 2024 the jury found the warning adequate but the design defective and awarded $7.75 million — some contemporaneous reports rounded it to $7.8 million — in what plaintiffs' counsel described as the first United States verdict against an aerosol dust remover manufacturer for harms flowing from misuse of the product.

The Eighth Circuit took it away on the element plaintiffs had treated as secondary. To make out a design defect under Minnesota law, McDougall had to establish not only that the product was in a defective condition but that it was unreasonably dangerous, and the panel concluded the evidence was legally insufficient on that second requirement.

Read together, the two rulings describe a migration. Design defect, in this circuit and on this product, is now a much harder road: a jury that accepted the theory was reversed, and the reversal came on a purely legal sufficiency ground that a retrial would not cure. What the September order preserves is the theory the McDougall jury actually rejected — warnings — plus a defendant class, retailers, that McDougall never reached. The plaintiffs' bar is not relitigating what it lost. It is pleading around it.

Four courts, one product, four answers

There is no multidistrict litigation for aerosol duster claims. Cases are scattered across district courts, and the results are genuinely inconsistent — which is ordinarily the argument for centralisation, and may become one.

Court	Case	Theory tested	Outcome
Tenth Circuit (D. Kan.)	Messerli v. AW Distributing, No. 23-3241 (3 Sep. 2025)	Design defect and failure to warn; decedent died of acute DFE intoxication in August 2020	Dismissal affirmed; Kansas's illegality defence survives comparative fault and bars recovery
Eighth Circuit (D. Minn.)	McDougall v. CRC Industries, No. 24-3614 (25 Feb. 2026)	Design defect, on behalf of a third party killed by an impaired driver	$7.75m verdict reversed; judgment as a matter of law for the manufacturer on the unreasonably dangerous element
N.D. Ill.	Piatek v. Norazza (order of 6 Jan. 2026)	Failure to warn plus claims based on the label's own representations	Failure to warn dismissed with prejudice; label-promise claim allowed to proceed
D. Minn.	The 18 September 2026 order	Failure to warn against manufacturers; § 544.41 seller exception as to retailers	Motion to dismiss denied; warning adequacy reserved for the record; retailers remain in

Four courts, four dispositions, and the differences are almost entirely doctrinal rather than factual. Kansas turns on an affirmative defence rooted in public policy. The Eighth Circuit turns on a sufficiency element of the prima facie case. The Northern District of Illinois separates a generalised duty to warn, which it rejected with prejudice, from the narrower proposition that a label which promises a safety feature must deliver it. Minnesota, now, turns on who counts as a mere seller.

For a plaintiff choosing a forum, that table is the whole analysis. For a defendant, it is an argument that the product is being judged by the map rather than by the evidence.

The regulatory vacuum behind the litigation

The reason this is being fought out in tort is that the regulatory route was opened and then closed.

In 2021 Families United Against Inhalant Abuse, an organisation of bereaved parents, petitioned the Consumer Product Safety Commission for a mandatory safety standard for aerosol duster products, docketed as CP 21-1. The Commission granted the petition. A proposed rulemaking followed in 2024 aimed at limiting DFE and comparable propellants in aerosol dusters. In August 2025 the proposal was withdrawn, along with several others, on the stated ground that they no longer aligned with agency priorities.

That sequence is load-bearing in two directions. Plaintiffs will use the petition record, the grant and the 2024 proposal as an admission by the agency that the hazard is real and known, and as evidence that a feasible alternative design exists — bitterant chemistry, propellant substitution, can design, sale restrictions were all on the table. Defendants will use the withdrawal to argue that the expert agency considered a standard and declined to impose one, and that a jury should not set a national design standard the Commission chose not to set. Neither argument is a preemption argument; a withdrawn proposed rule preempts nothing. But regulatory history is persuasive on state of the art, and both sides now have a version of it.

What it means for plaintiffs' firms, manufacturers and retailers

For plaintiffs' firms, the order is a filing signal rather than a valuation signal. Two propositions have now been established at the pleading stage in one of the two circuits that has taken this product seriously: warning adequacy survives to discovery, and a retailer that touched design or manufacture is not a mere seller. Firms with inhalant intake should expect the complaint template to shift toward warnings and the label's own representations, away from pure design defect, and toward pleading retailer participation with specificity rather than boilerplate. The Eighth Circuit has shown it will take a design case away after verdict, which makes the cost of pleading the wrong theory very high and very late.

For manufacturers, McDougall remains the most valuable precedent on the board and the September order does not disturb it. But the unreasonably dangerous element that carried the day there is a design-side defence; it does not answer a claim that the warning understated a known fatal risk, and it says nothing about representations made on the can. The bitterant allegation is the one to watch, because a safety feature that is pleaded as both ineffective and counterproductive converts internal formulation documents into the centre of the case.

For retailers and private-label partners, the practical change is document production. A § 544.41 affidavit is no longer a reliable exit in Minnesota where participation is pleaded, and the discovery that follows reaches merchandising, placement, theft data and internal knowledge of misuse — the same categories that have driven settlement values in other retail-channel torts. Compliance with Minn. Stat. § 325F.078 and its analogues in other states is worth auditing before it is requested rather than after.

For the litigation as a whole, the absence of an MDL is now conspicuous. Four courts have reached four answers on one product in eighteen months, the case inventory is growing, and the common discovery — formulation, bitterant testing, adverse event reporting, CPSC correspondence — is almost entirely shared. A centralisation motion before the Judicial Panel on Multidistrict Litigation is a matter of when rather than whether, and the party that files first will pick the proposed transferee district.

Frequently asked questions

What did the Minnesota federal court decide in the computer duster inhalation case?

On 18 September 2026 Judge Katherine M. Menendez of the District of Minnesota denied a motion to dismiss a putative class action arising from a death caused by intentional inhalation of an aerosol computer duster, holding that whether the manufacturers adequately warned that misuse could cause death cannot be determined at the pleading stage, and that Minnesota's seller exception does not defeat the claims against retailer defendants alleged to have participated in the products' design, manufacturing and distribution.

Are retailers like Walmart liable for aerosol duster injuries?

No liability has been established against any retailer. What the September order decides is narrower: a retailer alleged to have participated in a product's design, manufacture and distribution cannot use Minn. Stat. § 544.41 to be dismissed from strict liability claims at the outset, so it remains in the case for discovery.

Why did the Eighth Circuit reverse the $7.75 million CRC Industries duster verdict?

Because Minnesota law requires a design defect plaintiff to prove not only that the product was in a defective condition but that it was unreasonably dangerous, and the panel in McDougall v. CRC Industries concluded on 25 February 2026 that the trial evidence was legally insufficient on that element. It reversed and remanded for entry of judgment as a matter of law for CRC.

What is 1,1-difluoroethane and why is it dangerous?

DFE is the odourless fluorinated propellant in most aerosol computer dusters. Inhaled directly, it displaces oxygen and sensitises the heart to adrenaline, which can cause fatal cardiac arrest without warning — sudden sniffing death syndrome — while repeated use is associated with vitamin B12 depletion and spinal cord degeneration.

Did the CPSC ever regulate aerosol dusters?

It came close and stopped. The Commission granted petition CP 21-1 and issued a proposed rule in 2024 aimed at limiting DFE in aerosol dusters, then withdrew the proposal in August 2025 as no longer aligned with agency priorities. No mandatory federal safety standard for these products is in force.

How many deaths has the CPSC linked to aerosol duster inhalation?

Reports to the Commission between 2006 and 2022 identified 1,115 deaths and roughly 28,800 emergency room visits involving inhalation of 1,1-difluoroethane.

Is there an MDL for computer duster lawsuits?

No. There is no multidistrict litigation for aerosol duster claims, which is why the Tenth Circuit, the Eighth Circuit, the Northern District of Illinois and the District of Minnesota have produced four different outcomes on materially similar products within eighteen months.